Your browser doesn't support javascript.
loading
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.
Barroso, Fabio A; Judge, Daniel P; Ebede, Ben; Li, Huihua; Stewart, Michelle; Amass, Leslie; Sultan, Marla B.
Affiliation
  • Barroso FA; a Department of Neurology , Institute for Neurological Research Raúl Carrea, FLENI , Buenos Aires , Argentina.
  • Judge DP; b Johns Hopkins University Center for Inherited Heart Disease , Baltimore , MD , USA.
  • Ebede B; c Pfizer Inc , New York , NY , USA.
  • Li H; c Pfizer Inc , New York , NY , USA.
  • Stewart M; c Pfizer Inc , New York , NY , USA.
  • Amass L; c Pfizer Inc , New York , NY , USA.
  • Sultan MB; c Pfizer Inc , New York , NY , USA.
Amyloid ; 24(3): 194-204, 2017 Sep.
Article in En | MEDLINE | ID: mdl-28758793

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Benzoxazoles / Amyloid Neuropathies, Familial Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Amyloid Journal subject: BIOQUIMICA Year: 2017 Document type: Article Affiliation country: Argentina

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Benzoxazoles / Amyloid Neuropathies, Familial Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Amyloid Journal subject: BIOQUIMICA Year: 2017 Document type: Article Affiliation country: Argentina